Compare SG & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SG | CTKB |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 640.3M | 652.1M |
| IPO Year | 2021 | 2021 |
| Metric | SG | CTKB |
|---|---|---|
| Price | $6.12 | $4.53 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $8.43 | $5.63 |
| AVG Volume (30 Days) | ★ 3.6M | 555.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $679,474,000.00 | $193,015,000.00 |
| Revenue This Year | $7.64 | $5.42 |
| Revenue Next Year | $8.29 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.39 | ★ 17.67 |
| 52 Week Low | $4.49 | $2.37 |
| 52 Week High | $21.67 | $6.18 |
| Indicator | SG | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 51.86 |
| Support Level | $5.10 | $4.14 |
| Resistance Level | $6.12 | $4.60 |
| Average True Range (ATR) | 0.35 | 0.20 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 97.29 | 50.76 |
Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing. Its menu involves, Kids' meal, salads, sides, local items, Protein Plates, Desserts, Drinks and Others.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.